Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- Once-daily Trelegy Ellipta gains expanded COPD indication in Europe
- Statement: GSK supports GOLD committee’s efforts to further personalise COPD management
- ViiV Healthcare announces positive phase 3 results from the BRIGHTE study of fostemsavir at 48 weeks in heavily treatment-experienced patients with HIV
Tweets from GSK
-
GSK @GSK
#TBT to the early days of antibiotics research and development. Can you guess which decade these were taken?
about 15 hours ago
-
GSK @GSK
We’re not just discovering new antibiotics. We’re developing consumer healthcare products which reduce society’s dependence on existing antibiotics #AntibioticResistance #AMR
about 16 hours ago
-
GSK @GSK
We can’t stop #AntibioticResistance on our own. That’s why we’re proud of our long-term partnership in the US with @BARDA and @doddtra to develop new antibiotics @CDCgov #AMR gsk.to/2FpwsK4
about 20 hours ago
